SVB Securities cut shares of Selecta Biosciences ( NASDAQ:SELB – Free Report ) from an outperform rating to a market perform rating in a research report released on Friday, MarketBeat reports. The brokerage currently has $1.00 price objective on the stock. A number of other research firms also recently weighed in on SELB. TheStreet downgraded shares of Selecta Biosciences from a c- rating to a d- rating in a research report on Tuesday, May 16th. StockNews.com initiated coverage on shares of Selecta Biosciences in a report on Thursday.

https://www.dailypolitical.com/2023/08/19/selecta-biosciences-nasdaqselb-downgraded-by-svb-securities-to-market-perform.html

#dailypolitical